Clinical Trial: Development of a Prenatal Test for Fetal Aneuploidy Detection
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Prenatal Test for Fetal Aneuploidy Detection
Brief Summary: This is an observational study to develop and evaluate a blood based prenatal blood test. Pregnant women confirmed to be carrying a fetus with a chromosomal abnormality will be eligible. Subjects will be asked to provide a blood sample and a limited amount of clinical data that will be recorded on a case report form. All samples and clinical data will be stripped of subject identifiers prior to submission to Ariosa.
Detailed Summary:
Sponsor: Roche Sequencing Solutions
Current Primary Outcome: Identification of aneuploidy [ Time Frame: At enrollment ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Roche Sequencing Solutions
Dates:
Date Received: October 10, 2011
Date Started: November 2010
Date Completion: November 2017
Last Updated: July 14, 2016
Last Verified: July 2016